. Author manuscript; available in PMC: 2014 Jul 1.

Published in final edited form as: Mol Immunol. 2013 Jan 20;54(3-4):302–308. doi: 10.1016/j.molimm.2012.12.018

Table 3.

Transferred EAE clinical signs in mice treated with PBS or Mab 1379 before or after disease onset.

		CDI	Disease Onset	Disease Incidence
Treatment before disease onset	PBS-treated n=4	28.8	9d	100
Treatment before disease onset	mAb 1379-treated n=7	10.8^*	15.4d^*	86
Treatment before disease onset	PBS-treated n=4	44.2	8.3d	100
Treatment before disease onset	mAb 1379-treated n=9	26.7^*	9.4d	100

CDI = cumulative disease index, PI = post-induction of EAE.

Significantly different than PBS-treated controls, p<0.05.